These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial. Wasmann KA; de Groof EJ; Stellingwerf ME; D'Haens GR; Ponsioen CY; Gecse KB; Dijkgraaf MGW; Gerhards MF; Jansen JM; Pronk A; van Tuyl SAC; Zimmerman DDE; Bruin KF; Spinelli A; Danese S; van der Bilt JDW; Mundt MW; Bemelman WA; Buskens CJ J Crohns Colitis; 2020 Sep; 14(8):1049-1056. PubMed ID: 31919501 [TBL] [Abstract][Full Text] [Related]
4. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Regueiro M; Mardini H Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443 [TBL] [Abstract][Full Text] [Related]
6. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial. Meima-van Praag EM; van Rijn KL; Wasmann KATGM; Snijder HJ; Stoker J; D'Haens GR; Gecse KB; Gerhards MF; Jansen JM; Dijkgraaf MGW; van der Bilt JDW; Mundt MW; Spinelli A; Danese S; Bemelman WA; Buskens CJ Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):617-626. PubMed ID: 35427495 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study. Tonelli F; Giudici F; Asteria CR Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472 [TBL] [Abstract][Full Text] [Related]
8. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862 [TBL] [Abstract][Full Text] [Related]
9. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn's disease: A cohort study from northern India. Singh A; Kakkar C; Garg S; Arora K; Midha V; Mahajan R; Virk SS; Jain NP; Singh D; Sood K; Tripathi A; Gupta D; Kaushal IG; Galhotra RD; Saggar K; Sood A Indian J Gastroenterol; 2023 Oct; 42(5):668-676. PubMed ID: 37548863 [TBL] [Abstract][Full Text] [Related]
10. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431 [TBL] [Abstract][Full Text] [Related]
11. Combined strategies following surgical drainage for perianal fistulizing Crohn's disease: failure rates and prognostic factors. Herissay A; Siproudhis L; Le Balc'h E; Merlini L'Heritier A; Dewitte M; Wallenhorst T; Bouguen G; Brochard C Colorectal Dis; 2021 Jan; 23(1):159-168. PubMed ID: 32640112 [TBL] [Abstract][Full Text] [Related]
12. Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing. Wiese DM; Beaulieu D; Slaughter JC; Horst S; Wagnon J; Duley C; Annis K; Nohl A; Herline A; Muldoon R; Geiger T; Wise PE; Schwartz DA Inflamm Bowel Dis; 2015 Jul; 21(7):1594-9. PubMed ID: 25985245 [TBL] [Abstract][Full Text] [Related]
13. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease. Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625 [TBL] [Abstract][Full Text] [Related]
14. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease. Gu B; Venkatesh K; Williams AJ; Ng W; Corte C; Gholamrezaei A; Ghaly S; Xuan W; Paramsothy S; Connor S World J Gastroenterol; 2022 Jun; 28(23):2597-2608. PubMed ID: 35949350 [TBL] [Abstract][Full Text] [Related]
15. Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric Study. Reenaers C; Gillard RP; Coimbra C; Gillard RM; Meunier P; Lechanteur C; Baudoux E; Boutaffala L; Beguin Y; Louis É J Crohns Colitis; 2023 May; 17(5):728-737. PubMed ID: 36733215 [TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Surgery for Perianal Crohn's Fistula. Schaad M; Schoepfer A; Rossel JB; Barry MP; Rogler G; Hahnloser D; Medicina (Kaunas); 2024 Jun; 60(7):. PubMed ID: 39064464 [No Abstract] [Full Text] [Related]
17. A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. Spradlin NM; Wise PE; Herline AJ; Muldoon RL; Rosen M; Schwartz DA Am J Gastroenterol; 2008 Oct; 103(10):2527-35. PubMed ID: 18684178 [TBL] [Abstract][Full Text] [Related]